Fig. 2
From: Challenges in validation of combination treatment strategies for CRC using patient-derived organoids
Schematic overview of various CRC organoid-based enriched models and their applications. Healthy tissue is used alongside tumor tissue to assess the toxicity of the drugs under study. Created with BioRender